Erratum: Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation (BJU International (2010) 105:1 (738) doi:10.1111/j.1464-410X.2009.08714.x);Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation

BJU International

Volumn 105, Issue 1, 2010, Pages 73-78

  Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Polymorphisms; Premature ejaculation; Selective serotonin reuptake inhibitors; Serotonin transporter; Treatment outcome

Indexed keywords

SEROTONIN TRANSPORTER; SERTRALINE;

5 HTTLPR GENE; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; DRUG BLOOD LEVEL; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PREMATURE EJACULATION; PRIORITY JOURNAL; PROBABILITY; STIN2 GENE; STRUCTURED INTERVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 72149084933     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13062     Document Type: Erratum

References (42)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999 281 : 537 544 (Pubitemid 29081307)
2. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997 19 : 387 391
3. Aschka C, Himmel W, Ittner E et al. Sexual problems of male patients in family practice. J Fam Pract 2001 50 : 773 778
4. Safarinejad MR. Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2007 27 : 444 450
5. Safarinejad MR. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Clin Neuropharmacol 2006 29 : 243 252
6. Safarinejad MR, Hosseini SY. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double- blind placebo-controlled, fixed dose, randomized study. Int J Impot Res 2006 18 : 164 169
7. Roblin D. Premature ejaculation: diagnosis and pharmacotherapy. Int J Pharm Med 2000 14 : 313 318
8. Smits KM, Smits LJ, Schouten JS et al. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 2004 9 : 433 441
9. Lesch KP, Meyer J, Glatz K et al. The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. J Neural Transm 1997 104 : 1259 1266
10. Gelernter J, Kranzler H, Cubells JF. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol dependent subjects. Hum Genet 1997 101 : 243 246
11. Johnson BA, Javors MA, Roache JD et al. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 209 216
12. Heils A, Teufel A, Petri S et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996 66 : 2621 2624
13. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996 274 : 1527 1531
14. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999 88 : 61 6
15. Gunthert KC, Conner TS, Armeli S et al. Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction. Psychosom Med 2007 69 : 762 768
16. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000 5 : 32 8
17. Lesch KP. Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 2001 62 : 57 76
18. Fan JB, Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 2005 10 : 928 938 (Pubitemid 41486485)
19. Fiskerstrand CE, Lovejoy EA, Quinn JP. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 1999 458 : 171 174
20. Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 2003 23 : 563 567
21. Rausch JL, Johnson ME, Fei YJ et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 2002 51 : 723 732
22. Serretti A, Artioli P. From molecular biology to pharmacogenetics. A review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) 2004 174 : 490 503
23. Ng CH, Schweitzer I, Norman T, Easteal S. The emerging role of pharmacogenetics: implications for clinical psychiatry. Aust N Z J Psychiatry 2004 38 : 483 489
24. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry 2005 29 : 1074 1084
25. Heym J, Koe BK. Pharmacology of sertraline: a review. J Clin Psychiatry 1988 49 (Suppl. 40 5
26. Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001 21 : 556 560
27. Arafa M, Shamloul R. Efficacy of sertraline hydrochloride in treatment of premature ejaculation: a placebo-controlled study using a validated questionnaire. Int J Impot Res 2006 18 : 534 538
28. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998 159 : 1935 8
29. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double blind, randomised, placebo-controlled study. Am J Psychiatry 1994 151 : 1377 1379
30. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 : 822 828
31. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998 3 : 508 511
32. Pollock BG, Ferrell RE, Mulsant BH et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000 23 : 587 590
33. Serretti A, Cusin C, Lattuada E et al. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 1999 4 : 280 283 (Pubitemid 29292180)
34. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. J Clin Psychopharmacol 2000 20 : 105 107
35. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002 7 : 1115 1119
36. Serretti A, Cusin C, Rausch JL, Bondy B, Smeraldi E. Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis. Psychiatry Res 2006 145 : 61 5
37. Coolen LM, Peters HJ, Veening JG. Anatomical interrelationships of the medial preoptic area and other brain regions activated following male sexual behavior: a combined fos and tracttracing study. J Comp Neurol 1998 397 : 421 435
38. Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science 2002 297 : 1566 1569
39. Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdale. Science 2002 297 : 400 403
40. Kaiser R, Mulller-Oerlinghasen B, Filler D et al. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet 2002 114 : 323 328
41. Safarinejad MR. Polymorphisms of the serotonin transporter gene and their relation to premature ejaculation in individuals from Iran. Urology 2009 181 : 2656 2661
42. Abou-Sleiman PM, Hanna MG, Wood NW. Genetic association studies of complex neurological diseases. J Neurol Neurosurg Psychiatry 2006 77 : 1302 1304